JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Charalampous, K. D.
Right arrow Articles by Kinross-Wright, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Charalampous, K. D.
Right arrow Articles by Kinross-Wright, J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 145, Issue 2, 242-246, 1964
Copyright © 1964 by American Society for Pharmacology and Experimental Therapeutics

METABOLIC FATE OF ngr-(3, 4, 5-TRIMETHOXYPHENYL)-ETHYLAMINE (MESCALINE) IN HUMANS: ISOLATION AND IDENTIFICATION OF 3,4, 5-TRIMETHOXYPHENYLACETIC ACID

K. D. Charalampous 1, Antonio Orengo 1, K. E. Walker 1, and John Kinross-Wright 1

1 Department of Psychiatry, Baylor University College of Medicine, and Houston State Psychiatric Institute, Houston, Texas

Human subjects given labeled beta-(3,4 ,5-trimethoxyphyphenyl) -ethylanoine by mouth excrete an average of 81.9% of the administered dose in the urine during the first 12 hours. An average of 26.2% of the administered dose is excreted in the urine as free TMPA. TMPA given to humans by mouth produces no physiological or psychological changes.

Accepted on April 19, 1954






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1964 by the American Society for Pharmacology and Experimental Therapeutics.